All In Biotech

Free tool

FAERS Monitor: Blincyto

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125557 or its brand name (Blincyto, Blinatumomab). Reports on generic versions are filed under their own applications.

Reports

10,722

Serious

8,619

80% of reports

Hospitalization

2,884

Death reported

1,935

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia1,187
  • cytokine release syndrome1,150
  • acute lymphocytic leukaemia recurrent1,121
  • off label use793
  • death674
  • neurotoxicity584
  • drug ineffective448
  • headache379
  • neutropenia333
  • febrile neutropenia313
  • therapy non-responder291
  • tremor287
  • seizure279
  • infection268
  • acute lymphocytic leukaemia251

Reports by year received

View as table
YearReports
20148
2015446
2016712
2017808
2018803
2019865
2020789
20211,013
2022959
20231,100
20241,297
20251,065
2026857

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,437 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute lymphocytic leukaemia recurrentSignal1,1211504.91395.5952,830
acute lymphocytic leukaemiaSignal251190.7167.843,007
cytokine release syndromeSignal1,150119.2112.7127,120
neurotoxicitySignal58467.662.437,010
therapy non-responderSignal29112.811.43,133
febrile neutropeniaSignal3139.38.32,305
pyrexiaSignal1,1876.76.45,884
neutropeniaSignal3334.84.31,006
seizureSignal2794.74.2824
infectionSignal2683.63.2512
tremorSignal2873.43.0486
off label use7931.81.7280
death6741.51.4130
headache3791.21.111
drug ineffective4480.70.679

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.